Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development

Author

R. Vergallo

h-index 40 View on Semantic Scholar

We have 4 of 363 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

"Lipoprotein(a) across coronary plaque phenotypes from high-risk to layered plaque: An OCT analysis from the RELACS registry".

Increasing Lp(a) levels were associated with OCT-defined coronary plaque phenotypes related to vulnerability and instability, including high-risk and layered plaques, and given the limited patient-level sample size, these findings should be considered exploratory and hypothesis-generating.

V. Acerbo, A. Cesaro, F. Biccirè et al. · 0 citations
Review Sep 2026

Aortic valve replacement in patients with small aortic annuli: a systematic review and network meta-analysis.

Objectives Up to 40% of patients with aortic stenosis undergoing valve replacement have a small annulus, a key determinant of valve hemodynamics, durability, and clinical outcomes. Surgical and transcatheter approaches have been reported to be determined by prosthesis design, considering the operative mortality and mor...

J. Chiabrando, M. Lombardi, E. Elia et al. · 0 citations
Aug 2026

Cangrelor in elderly patients undergoing percutaneous coronary intervention: findings from the ICARUS Registry.

Elderly patients were at higher risk of NACE, driven by an increased risk of both ischemic and bleeding events, the latter including access-site and nonaccess-site hemorrhages of both minor and major severity.

S. Benenati, F. Gragnano, Sebastiano Stratoti et al. · 1 citation
Aug 2026

De-escalation of antiplatelet therapy to evaluate platelet reactivity and clinical outcomes after coronary stenting in patients at high bleeding risk and recent acute coronary syndrome: Rationale and design of the DESC-HBR trial.

DesC-HBR is the first randomized trial directly comparing multiple P2Y12 inhibitor de-escalation strategies in HBR patients post-ACS and will provide information to guide individualized antiplatelet strategies balancing ischemic protection and bleeding mitigation in HBR patients.

Francesco Costa, G. Vizzari, S. Zecchino et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.